Key result
AI and ML may improve syncope management via enhanced diagnosis and risk assessment despite medicolegal challenges.
Why the study?
Current risk stratification algorithms do not completely delineate which syncope patients benefit from hospitalization and interventions, often leading to unnecessary and costly admissions.
Can artificial intelligence and machine learning enhance the management and risk stratification of patients with syncope?
Can artificial intelligence and machine learning enhance the management and risk stratification of patients with syncope?
This collaborative statement highlights the potential of AI to improve syncope diagnosis and risk stratification, while noting remaining medicolegal and ethical challenges.
Should not yet change syncope practice; leaves open AI's role pending prospective validation.
Syncope, a form of transient loss of consciousness, remains a complex medical condition for which adverse cardiovascular outcomes, including death, are of major concern but rarely occur. Current risk stratification algorithms have not completely delineated which patients benefit from hospitalization and specific interventions. Patients are often admitted unnecessarily and at high cost. Artificial intelligence (AI) and machine learning may help define the transient loss of consciousness event, diagnose the cause, assess short- and long-term risks, predict recurrence, and determine need for hospitalization and therapeutic intervention; however, several challenges remain, including medicolegal and ethical concerns. This collaborative statement, from a multidisciplinary group of clinicians, investigators, and scientists, focuses on the potential role of AI in syncope management with a goal to inspire creation of AI-derived clinical decision support tools that may improve patient outcomes, streamline diagnostics, and reduce health-care costs.
No takes yet. Share an insight, caveat, or question.
Statz et al. (2023) conducted a review in Syncope. Artificial intelligence (AI) and machine learning was evaluated. Artificial intelligence and machine learning may improve syncope management by enhancing diagnosis, risk assessment, and clinical decision support, despite existing medicolegal and ethical challenges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: